Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: Effects on tumour biomass, apoptosis and neuronal tissue histology

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 67, Issue 5, 2002, Pages 283-292

  Leaver, H A ^a,c   Wharton, S B ^b   Bell, H S ^a   Leaver Yap, I M M ^a   Whittle, I R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c National Science Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA LINOLENIC ACID; UNSATURATED FATTY ACID;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOMASS; BRAIN TISSUE; CANCER CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DRUG ACTIVITY; DRUG BIOAVAILABILITY; GLIOMA; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR REGRESSION;

EID: 6444245382     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0431     Document Type: Article

References (33)

1. Das U. N., Prasad V. V. K., Reddy D. R. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 1995; 94: 147-155.
2. Williams J. R., Leaver H. A., Ironside J. W., Miller E. P., Whittle I. R., Gregor A. Apoptosis in human primary brain tumours: Actions of arachidonic acid. Prostaglandins Leukot Essent Fatty Acids 1998; 58: 193-200.
3. Leaver H. A., Bell H. S., Rizzo M. T., Ironside J. W., Gregor A., Wharton S. B., Whittle I. R. Antitumour and pro-apoptotic actions of highly unsaturated fatty acids in glioma. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 19-29.
4. Koki A. T., Khan N. K., Woerner B. M., et al. Characterisation of Cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: Evidence for potential utility of COX-2 inhibitors in epithelial cancers. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 13-18.
5. Payner T. D., Leaver H. A., Whittle I. R., Rizzo M. T. Involvement of the cyclooxygenase 2 pathway in regulation of growth and tumour associated angiogenesis in human malignant glioma. Proceedings of the Eicosanoid & Bioactive Lipids in Cancer Symposium, USA, October 2001.
6. Leaver H. A., Thomson D., Williams J. R., Bell H., Whittle I. R. Essential fatty acid induced tumour regression in experimental glioma. Br J Neurosurg 1999; 13: 108.
7. Whittle I. R. Can experimental models of implantation glioma be improved? A study of pure and mixed glioma cell line tumours. J Neuro-Oncol 1998; 36: 231-242.
8. Leaver H. A., Williams J. R., Gregor A., Ironside J. W., Miller E. P., Su B. H., Prescott R. J., Whittle I. R. Dynamics of reactive oxygen intermediate production by human brain tumours: n-6 essential fatty acid effects. Eur J Clin Invest 1999; 29: 220-231.
9. Royds J. A., Ironside J. W., Taylor C. B. An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system. Acta Neuropath 1986; 70: 320-326.
10. Bell H., Wharton S., Leaver H. A., Whittle I. R. Effects of n-6 essential fatty acids on glioma invasion and growth: Experimental studies using human and rodent glioma spheroids in collagen gels. J Neurosurg 1999; 91: 989-996.
11. Bell H., Whittle I. R., Walker M., Leaver H. A., Wharton S. Necrosis and apoptosis in glioma: Experimental findings using spheroid culture systems. Neuropathol Appl Neurobiol 2001; 27: 291-304.
12. Swaroop G. R., Kelly P. A., Bell H. S., Shinoda J., Yamaguchi S., Whittle I. R. The effects of chronic nitric oxide synthase suppression on glioma pathophysiology. Br J Neurosurg 2000; 14: 543-548.
13. Wharton S. B., Hamilton F. A., Chan W. K., Chan K. K., Anderson J. R. Proliferation and cell death in oligodendrogliomas. Neuropathol Appl Neurobiol 1998; 24: 21-28.
14. Horrobin D. F. Essential fatty acids, lipid peroxidation and cancer. In: Horrobin D. F., ed. New Approaches to Cancer. London: Churchill Communications Europe, 1994; 3-29.
15. Goddard D. H., Bomalaski J. S., Lipper S., Shorr R. G., Clark M. A. Phospholipase A2-mediated inflammation induces regression of malignant gliomas. Cancer Lett 1996; 102: 1-6.
16. Hernandez M., Bayon Y., Sanchez Crespo M., Nieto M. L. Signaling mechanisms involved in the activation of arachidonic acid metabolism in human astrocytoma cells by tumor necrosis factor-alpha: Phosphorylation of cytosolic phospholipase A2 and transactivation of cyclooxygenase-2. J Neurochem 1999; 73: 1641-1649.
17. Rudra P. K., Krokan H. E. Cell-specific enhancement of doxorubicin toxicity in human tumour cells by docosahexaenoic acid. Anticancer Res 2001; 21: 29-38.
18. Kokoglu E., Tuter Y., Yazici Z., Sandikci K. S., Sonmez H., Ulakoglu E. Z., Ozyurt E. Profiles of the fatty acids in the plasma membrane of human brain tumors. Cancer Biochem Biophys 1998; 16: 301-312.
19. Van der Merwe C. F., Booyens J., Katzeff I. E. Oral gamma-linolenic acid in 21 patients with untreatable malignancy. An ongoing pilot open clinical trial. Br J Clin Pract 1987; 41: 907-915.
20. Wu G., Lu Z. H., Xie X., Li L., Ledeen R. W. Mutant NG 108-15 cells (NG-CR72) deficient in GM1 synthase respond aberrantly to axonogenic stimuli and are vulnerable to calcium-induced apoptosis: They are rescued with LIGA-20. J Neurochem 2001; 76 690-702.
21. Black P., Hand C. M., Vender J. R., Finkelstein S. D. Chemotherapy in experimental brain tumor, part 2: Pretreatment with leukotriene C4 prolongs survival. J Neurooncol 1998; 36: 7-19.
22. Whittle I. R., Piper I. R., Miller J. D. The contribution of arachidonic acid to the aetiology and pathophysiology of focal brain oedema; studies using an infusion oedema model. Acta Neurochir (Wien) 1991; 113: 57-68.
23. Jacobsson S. O., Wallin T., Fowler C. J. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther 2001; 299: 951-959.
24. 2+ in neuroblastoma x glioma hybrid NG 108-15 cells. Biochem Biophys Res Commun 1996; 229: 58-64.
25. Ramer R., Brune K., Pahl A., Hinz B. R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochem Biophys Res Commun 2001; 286: 1144-1152.
26. Wagenknecht B., Gulbins E., Lang F., Dichgans J., Weller M. Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells. FEBS Lett 1997; 409: 17-23.
27. Zhang L., Reith M. E. Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur J Pharmacol 1996; 315: 345-354.
28. Graeber T. G., et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88-91.
29. Yavin E., Yavin Z., Menkes J. H. Effect of essential fatty acids on proliferation of two neural tumor lines. Neurobiology 1975; 5: 214-220.
30. Sun S. H., Ou H. C., Jang T. H., Lin L. B., Huang H. M. Altered phospholipid metabolism in sodium butyrate-induced differentiation of C6 glioma cells. Lipids 1997; 32: 273-282.
31. Dunican D.J., Griffiths R., Williams D. C., O'Neill L. A. Endothelin-1 increases arachidonic acid release in C6 glioma cells through a potassium-modulated influx of calcium. J Neurochem 1996; 67: 830-837.
32. Hakumaki J. M., Poptani H., Sandmair A. M., Yla-Herttuala S., Kauppinen R. A. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis. Nat Med 1999; 5: 1323-1327.
33. Cook H. W., Spence M. W. Interaction of (n-3) and (n-6) fatty acids in desaturation and chain elongation of essential fatty acids in cultured glioma cells. Lipids 1987; 22: 613-619.